Company intelligence / Profile preview

Navican Genomics

Salt Lake City, Utah, United States

Ownership: Private
Employees: ~69
Development stage: Other

Overview

Navican Genomics was a precision medicine company focused on cancer care that ceased operations. The company developed TheraMap, a comprehensive end-to-end solution for precision cancer care that analyzed the genetic makeup of patient tumors to provide personalized treatment recommendations and match patients with appropriate clinical trials.

Therapeutic areas: Oncology
Industry: Molecular Diagnostics

Partnerships

PhilipsIlluminaN-of-One

Beyond the preview

Go deeper on Navican Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Navican Genomics.

Explore the full profile